Azasetron

DB16837InvestigationalSmall molecule

Azasetron: Overview.

Chemical structure of Azasetron
Mechanism
Curator reviewed
Formula / weight
C17H20ClN3O3 · 349.82 g/mol (avg)

Resolves to

Compound
UNII77HC7URR9ZCAS123040-69-7ChEMBLCHEMBL1598608ChEBI91712
Structure
InChIKeyWUKZPHOXUVCQOR-UHFFFAOYSA-NSMILESCN1C(=O)COC2=C(C=C(Cl)C=C12)C(=O)NC1CN2CCC1CC2
Transporters
P08183ABCB1

What you can answer from here — as of September 16, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1TransporterSubstrate / inhibitor direction, not just membership
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of Azasetron, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In